Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BH02 Vildagliptin
D07080 Vildagliptin (JAN/USAN/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
396 Antidiabetic agents
3969 Others
D07080 Vildagliptin (JAN/USAN/INN)
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01601 DPP-4 inhibitor
D07080 Vildagliptin
Drug classes [BR:br08332]
Antidiabetic agent
DG01601 DPP-4 inhibitor
D07080 Vildagliptin
DG02044 Hypoglycemic agent
D07080 Vildagliptin
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Peptidyl-peptidases
DPP4 (CD26)
D07080 Vildagliptin (JAN/USAN/INN) <JP>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D07080
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D07080
Other DBs
CAS:
274901-16-5
PubChem:
51091422
LigandBox:
D07080
NIKKAJI:
J2.160.644H
KCF data
ATOM 22
1 C1z C 16.8876 -17.1565
2 C1x C 16.1956 -18.5404
3 C1y C 16.1956 -19.7858
4 C1y C 15.7113 -19.0939
5 C1z C 17.9947 -19.0939
6 C1x C 14.6042 -20.2010
7 C1x C 17.3027 -20.8237
8 C1x C 15.7113 -17.7793
9 C1x C 16.8876 -19.7166
10 C1x C 17.9947 -17.7793
11 N1b N 16.8876 -15.8419
12 O1a O 19.1890 -18.3949
13 C1b C 18.0860 -15.1499
14 C5a C 19.2677 -15.8324
15 O5a O 19.2678 -17.2254
16 N1y N 20.4413 -15.1547
17 C1x C 20.8738 -16.4560
18 C1x C 22.2327 -16.4309
19 C1x C 22.6287 -15.1307
20 C1y C 21.5145 -14.3523
21 C3b C 21.4915 -12.9362
22 N3a N 21.5178 -11.5519
BOND 25
1 1 2 1
2 2 3 1
3 8 4 1
4 4 9 1
5 9 5 1
6 5 10 1
7 10 1 1
8 1 8 1
9 3 6 1
10 3 7 1
11 4 6 1
12 5 7 1
13 1 11 1
14 5 12 1
15 11 13 1
16 13 14 1
17 14 15 2
18 14 16 1
19 16 17 1
20 17 18 1
21 18 19 1
22 19 20 1
23 16 20 1
24 20 21 1 #Down
25 21 22 3